Repligen (RGEN) Q3 2026 Earnings Call: Record Revenue and Raised Guidance
Source Tradingkey
Key Takeaways
- Repligen reported record Q3 2026 revenue of $209 million, up 11% year over year on a reported basis and 12.5% organically.
- Adjusted operating income increased 24% to $33 million, while adjusted operating margin expanded 170 basis points to 15.9%.
- Consumables revenue grew 20%, and services grew more than 20%. Capital equipment orders increased in the mid-teens and reached their highest quarterly level in five years, although equipment revenue declined as deliveries shifted into 2027.
- Chromatography revenue grew more than 50%, proteins exceeded 40% growth, and analytics rose 20%. Filtration declined 11%, reflecting ATF-related headwinds, the Polymem divestiture, foreign exchange and equipment timing.
- Repligen raised its 2026 revenue guidance to $844 million-$852 million, including approximately $24 million from BioLife following the October 6 acquisition close.
- Management said Repligen is positioned to grow reported revenue by at least 25% in 2027 and exceed $1 billion, assuming high-single-digit market growth and no material foreign-exchange change. This is a planning framework, not formal 2027 guidance.
Core Financial Results
| Metric | Q3 2026 | Change / context |
|---|---|---|
| Revenue | $209 million | Record quarter; up 11% reported and 12.5% organically |
| Adjusted gross profit | $111 million | — |
| Adjusted gross margin | 53.0% | Down 30 basis points year over year |
| Adjusted operating income | $33 million | Up 24% year over year |
| Adjusted operating margin | 15.9% | Up 170 basis points |
| Adjusted EBITDA | $44 million | 20.9% margin |
| Adjusted net income | $30 million | Up 16% year over year |
| Adjusted diluted EPS | $0.53 | Up 15% from $0.46 |
| Cash, cash equivalents and marketable securities | $863 million | Up $53 million sequentially |
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Recommended Articles
Fed October Rate Decision Preview: Rate Hike Pause Has Become Consensus, How Will US Stocks, Dollar, and Gold React?The Federal Reserve will announce its October interest rate decision at 14:00 Eastern Time on October 28, and Fed Chair Warsh will hold a press conference at 14:30. Markets currently wide
The Federal Reserve will announce its October interest rate decision at 14:00 Eastern Time on October 28, and Fed Chair Warsh will hold a press conference at 14:30. Markets currently wide
Anthropic files for a $2 trillion IPO — the $80.7 billion loss is the decoy, the $450 billion compute bill is the riskAnthropic publicly filed its S-1 on October 26, revealing $16.29 billion of first-half revenue (+1,304% year over year) and a $80.7 billion net loss — of which $72.4 billion is a non-cash convertible-note charge. The real number is the $450 billion of signed, mostly non-cancelable compute commitments. Here is what the filing says, why NVDA, ARM and MU are the tradeable read-through, and the conditions that decide whether the AI trade passes its first public valuation test.
Anthropic publicly filed its S-1 on October 26, revealing $16.29 billion of first-half revenue (+1,304% year over year) and a $80.7 billion net loss — of which $72.4 billion is a non-cash convertible-note charge. The real number is the $450 billion of signed, mostly non-cancelable compute commitments. Here is what the filing says, why NVDA, ARM and MU are the tradeable read-through, and the conditions that decide whether the AI trade passes its first public valuation test.
Tesla jumps 5% as Barclays puts a $450 target on the SpaceX merger — the chart was already pointing to 431Tesla closed at $391.62 on October 26, up 5.21%, after Barclays upgraded the stock to Overweight and lifted its target to $450 from $370, citing a sharp inflection in Robotaxi miles and a potential SpaceX merger. The move also completed a double bottom at $345.88 and $349.33, with a neckline at $388.56 and a measured target of $431.24. Here is what the upgrade actually says, why the chart and the analyst now point the same way, and what would break the target.
Tesla closed at $391.62 on October 26, up 5.21%, after Barclays upgraded the stock to Overweight and lifted its target to $450 from $370, citing a sharp inflection in Robotaxi miles and a potential SpaceX merger. The move also completed a double bottom at $345.88 and $349.33, with a neckline at $388.56 and a measured target of $431.24. Here is what the upgrade actually says, why the chart and the analyst now point the same way, and what would break the target.
Euro weakens below 1.1200 as traders brace for Fed, ECB rate decisionsThe EUR/USD pair extends the decline near 1.1170 during the early Asian trading hours on Tuesday, pressured by risk-off sentiment. Markets might turn cautious later in the day ahead of the US Federal Reserve (Fed) and European Central Bank (ECB) interest rate decisions later this week.
The EUR/USD pair extends the decline near 1.1170 during the early Asian trading hours on Tuesday, pressured by risk-off sentiment. Markets might turn cautious later in the day ahead of the US Federal Reserve (Fed) and European Central Bank (ECB) interest rate decisions later this week.
Bitcoin falls below the $80,000 mark as the October FOMC decision approaches, threatening a further dip toward $75,000.On October 26, Bitcoin (BTC) again lost the key psychological mark o
